Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline'
(NASDAQ: RCKT) Delayed: 3.47 +0.13 (3.89%)
Previous Close $3.34    52 Week High $ 
Open $3.33    52 Week Low $ 
Day High $3.50    P/E N/A 
Day Low $3.27    EPS $ 
Volume 1,159,069